Literature DB >> 18576213

Neurofibromatosis type 1 association with moyamoya disease.

Filiz Koc1, Deniz Yerdelen, Zafer Koc.   

Abstract

The neurofibromatoses are genetic disorders of the nervous system that primarily affect the development and growth of neural (nerve) cell tissues. The neurofibromatoses are classified as neurofibromatosis type 1 (NF1) and neurofibromatosis type 2 (NF2). NF1 is the more common type of the neurofibromatoses. The gene responsible for NF1 is located on the chromosome region 17q11.2 and for familial moyamoya disease on chromosome 17q25. This article reports on a 20-year-old female with neurofibromatosis-1 who developed moyamoya syndrome. More extensive reports and further investigations of such families having this combination will certainly provide a better understanding of this link in the near future.

Entities:  

Mesh:

Year:  2008        PMID: 18576213     DOI: 10.1080/00207450801898279

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  9 in total

Review 1.  Concurrent Graves' disease and intracranial arterial stenosis/occlusion: special considerations regarding the state of thyroid function, etiology, and treatment.

Authors:  Shigeo Ohba; Toru Nakagawa; Hideki Murakami
Journal:  Neurosurg Rev       Date:  2011-03-19       Impact factor: 3.042

2.  Moyamoya syndrome associated with neurofibromatosis type 1 in a pediatric patient.

Authors:  Natália Battisti Serafini; Cássio Battisti Serafini; Alanna Santoro Vinhas; Marcio Barbosa Godinho
Journal:  An Bras Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.896

3.  Management of glioblastoma in an NF1 patient with moyamoya syndrome: a case report.

Authors:  Hideyuki Arita; Yoshitaka Narita; Makoto Ohno; Yasuji Miyakita; Yoshiko Okita; Takafumi Ide; Soichiro Shibui
Journal:  Childs Nerv Syst       Date:  2012-10-30       Impact factor: 1.475

Review 4.  Neurovascular manifestations of connective-tissue diseases: A review.

Authors:  Sarasa T Kim; Waleed Brinjikji; Giuseppe Lanzino; David F Kallmes
Journal:  Interv Neuroradiol       Date:  2016-08-10       Impact factor: 1.610

5.  Moyamoya syndrome and neurofibromatosis type 1.

Authors:  Euthymia Vargiami; Evdoxia Sapountzi; Dimitris Samakovitis; Spyros Batzios; Maria Kyriazi; Athanasia Anastasiou; Dimitrios I Zafeiriou
Journal:  Ital J Pediatr       Date:  2014-06-21       Impact factor: 2.638

Review 6.  Phakomatoses and cutaneous manifestations associated with moyamoya disease and syndrome.

Authors:  Maja Tomaszewska; Lidia Strzelczuk-Judka; Danuta Ostalska-Nowicka; Katarzyna Jończyk-Potoczna
Journal:  Postepy Dermatol Alergol       Date:  2021-01-06       Impact factor: 1.837

7.  Identification of immune-infiltrated hub genes as potential biomarkers of Moyamoya disease by bioinformatics analysis.

Authors:  Fa Jin; Chuanzhi Duan
Journal:  Orphanet J Rare Dis       Date:  2022-02-23       Impact factor: 4.123

8.  An unusual cause of subarachnoid haemorrhage in a patient with newly diagnosed neurofibromatosis: a case report.

Authors:  Chisha Weerasinghe; Prem Jesudason; Daniel Peckham
Journal:  Cases J       Date:  2009-08-11

9.  Multimodal evaluation of the cerebrovascular reserve in Neurofibromatosis type 1 patients with Moyamoya syndrome.

Authors:  Alessandra D'Amico; Lorenzo Ugga; Sirio Cocozza; Sara Maria Delle Acque Giorgio; Domenico Cicala; Claudia Santoro; Daniela Melis; Giuseppe Cinalli; Arturo Brunetti; Sabina Pappatà
Journal:  Neurol Sci       Date:  2020-07-10       Impact factor: 3.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.